Log in to your Inderes Free account to see all free content on this page.

Vitrolife

109.80 SEK

Less than 1K followers

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vitrolife

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

Dividend yield

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)197.50215.80560.00186.20194.70215.00137.00
Shares108.6108.6114.7135.4135.4135.4135.4
Market cap21,438.623,425.164,204.625,220.326,371.629,121.118,556.3
Enterprise value20,749.122,451.565,947.526,867.327,599.630,075.1-
EV/S14.018.039.28.37.98.3-
EV/EBITDA39.156.9145.236.7neg.31.3-
EV/EBIT42.560.7151.541.1neg.38.4-
P/E56.081.7188.364.0neg.56.7neg.
P/B11.9311.614.191.512.072.132.35
P/S14.518.838.27.87.58.15.4
Dividend yield0.5 %0.4 %0.1 %0.5 %0.5 %0.5 %0.8 %
Equity ratio84.1 %87.5 %79.0 %81.5 %77.9 %78.2 %71.0 %
Gearing ratio4.2 %3.1 %15.5 %13.3 %16.4 %15.3 %20.3 %
Login required

This content is only available for logged in users